Orchestra BioMed Inc.
OBIO | NASDAQ
$6.36
+$0.11 (+1.76%)
Sep 22, 2026, 12:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.01 | -2.41 | -6.17 | -7.56 | -544.86 | -1.51K |
PEG Ratio | 0.18 | -0.20 | -0.51 | 0 | -4.63 | n/a |
PS Ratio | 4.76 | 55.83 | 109.91 | 71.95 | -263.60 | 45.93 |
PB Ratio | 2.51 | 4.47 | 4.46 | 4.84 | -2.89 | -5.40 |
P/FCF Ratio | -3.22 | -2.90 | -6.57 | -8.51 | -10.46 | -9.80 |
P/OCF Ratio | -3.25 | -2.91 | -6.58 | -8.68 | -10.61 | -10.01 |
OCF/S Ratio | -146.24 | -1.92K | -1.67K | -829.01 | 2.48K | -459.11 |
Debt / Equity Ratio | 0.25 | 0.50 | 0.02 | 0.23 | -0.08 | -0.19 |
Quick Ratio | 6.43 | 4.26 | 7.94 | 4.55 | 0.92 | 2.52 |
Current Ratio | 6.45 | 4.27 | 7.95 | 4.56 | 0.92 | 2.52 |
Asset Turnover | 0.29 | 0.03 | 0.03 | 0.04 | -0.06 | 0.15 |
Interest Coverage | -45.13 | n/a | n/a | n/a | -23.52 | n/a |
Return on Equity | -83.15% | -185.16% | -72.19% | -63.97% | 32.31% | 43.99% |
Return on Assets | -45.88% | -80.11% | -51.59% | -35.17% | -170.13% | -56.06% |
Return on Invested Capital | -52.40% | -106.25% | -60.84% | -42.03% | -663.19% | -67.62% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 99.43% | 92.27% | 93.26% | 90.89% | 125.45% | 97.46% |
Net Profit Margin | -157.40% | -2.31K% | -1.78K% | -951.26% | 2.94K% | -374.45% |
Pretax Profit Margin | -157.40% | -2.31K% | -1.78K% | -951.26% | 2.94K% | -374.45% |
Operating Profit Margin | -154.73% | -2.44K% | -1.87K% | -924.34% | 2.79K% | -328.81% |
FCF Margin | -147.70% | -1.93K% | -1.67K% | -845.74% | 2.52K% | -468.56% |
EBITDA Margin | -153% | -2.3K% | -1.77K% | -944.98% | 2.8K% | -326.41% |
Add to Watchlist
Select watchlists to add or remove OBIO